Summer Dewdney to Tumor Suppressor Protein p53
This is a "connection" page, showing publications Summer Dewdney has written about Tumor Suppressor Protein p53.
Connection Strength
0.472
-
TP53 Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study. J Clin Oncol. 2022 10 01; 40(28):3289-3300.
Score: 0.193
-
Mutated p53 portends improvement in outcomes when bevacizumab is combined with chemotherapy in advanced/recurrent endometrial cancer: An NRG Oncology study. Gynecol Oncol. 2021 04; 161(1):113-121.
Score: 0.176
-
Use of cervical mucus to screen for gynecological malignancies: a pilot study. Mod Pathol. 2013 Nov; 26(11):1508-13.
Score: 0.104